Acute Myelogenous Leukemia (e-bog) af -
Nagarajan, Lalitha (redaktør)

Acute Myelogenous Leukemia e-bog

436,85 DKK (inkl. moms 546,06 DKK)
Acute myelogenous leukemia (AML), is the most common form of leukemia in adults. AML is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as the population ages. Over the past 15 years, genetic mechanisms underlying AML have begun to unf...
E-bog 436,85 DKK
Forfattere Nagarajan, Lalitha (redaktør)
Forlag Springer
Udgivet 20 marts 2010
Genrer Cybernetics and systems theory
Sprog English
Format pdf
Beskyttelse LCP
ISBN 9780387692593
Acute myelogenous leukemia (AML), is the most common form of leukemia in adults. AML is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as the population ages. Over the past 15 years, genetic mechanisms underlying AML have begun to unfold. Additional research in this area has helped identify key components and characteristics. Consequently, targeted therapy of AML is receiving much attention. It is the hope of researchers that as with chronic myelogenous leukemia (CML), and the drug, Gleevec, a targeted therapy for AML will be discovered.